These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32198771)

  • 21. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline clinical characteristics of heart failure patients with reduced ejection fraction enrolled in the BUDAPEST-CRT Upgrade trial.
    Merkely B; Gellér L; Zima E; Osztheimer I; Molnár L; Földesi C; Duray G; Wranicz JK; Németh M; Goscinska-Bis K; Hatala R; Sághy L; Veres B; Schwertner WR; Fábián A; Fodor E; Goldenberg I; Kutyifa V; Kovács A; Kosztin A
    Eur J Heart Fail; 2022 Sep; 24(9):1652-1661. PubMed ID: 35791276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative long-term outcomes after cardiac resynchronization therapy in right ventricular paced patients versus native wide left bundle branch block patients.
    Tayal B; Gorcsan J; Delgado-Montero A; Goda A; Ryo K; Saba S; Risum N; Sogaard P
    Heart Rhythm; 2016 Feb; 13(2):511-8. PubMed ID: 26545939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular electrical activation during right ventricular pacing in heart failure patients with LBBB: visualization by electrocardiographic imaging and implications for cardiac resynchronization therapy.
    Varma N
    J Electrocardiol; 2015; 48(1):53-61. PubMed ID: 25301520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of His-bundle pacing upgrade after long-term right ventricular pacing and/or pacing-induced cardiomyopathy: Insights into disease progression.
    Vijayaraman P; Herweg B; Dandamudi G; Mittal S; Bhatt AG; Marcantoni L; Naperkowski A; Sharma PS; Zanon F
    Heart Rhythm; 2019 Oct; 16(10):1554-1561. PubMed ID: 30930330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
    Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
    JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of paced left ventricular dyssynchrony on left ventricular reverse remodeling after cardiac resynchronization therapy.
    Gauthey A; Willemen E; Lumens J; Ploux S; Bordachar P; Ritter P; Prinzen FW; Lejeune S; Pouleur AC; Garnir Q; Marchandise S; Scavée C; Wauters A; le Polain de Waroux JB
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):494-502. PubMed ID: 31908084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.
    Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Bhat G; Cowger J; Abdullah M; Dhawan R; Trivedi JR; Slaughter MS; Gopinathannair R
    Sci Rep; 2020 Feb; 10(1):2573. PubMed ID: 32054868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis.
    Lu W; Lin J; Dai Y; Chen K; Zhang S
    Heart Fail Rev; 2022 Mar; 27(2):507-516. PubMed ID: 33638772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for developing pacing induced LV dysfunction: Experience from a tertiary center in the UK.
    Kanthasamy V; Papageorgiou N; Bajomo T; Monkhouse C; Creta A; Finlay M; Lambiase PD; Moore P; Sporton S; Earley MJ; Schilling RJ; Hayward C; Providência R; Hunter RJ; Chow AW; Muthumala A
    Pacing Clin Electrophysiol; 2022 Mar; 45(3):365-373. PubMed ID: 35023176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacing.
    Rath B; Willy K; Wolfes J; Ellermann C; Reinke F; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2021 Jun; 110(6):877-883. PubMed ID: 33320290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy with His bundle pacing.
    Boczar K; Sławuta A; Ząbek A; Dębski M; Vijayaraman P; Gajek J; Lelakowski J; Małecka B
    Pacing Clin Electrophysiol; 2019 Mar; 42(3):374-380. PubMed ID: 30659629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pacing-induced cardiomyopathy in patients with preserved ejection fraction undergoing permanent cardiac pacemaker placement.
    Cho JY; Kim SS; Jeong HK; Choi IY; Kim HK; Ki YJ; Choi DH; Park KH
    J Interv Card Electrophysiol; 2024 Mar; 67(2):363-369. PubMed ID: 37726570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.